{"pmid":32316751,"title":"Coronavirus disease 2019: reassembly attack of coronavirus.","text":["Coronavirus disease 2019: reassembly attack of coronavirus.","There have been three major global outbreaks of acute respiratory disease caused by coronavirus in the last two decades. The ongoing Coronavirus Disease 2019 (COVID-19) first emerged in Wuhan, China, is the most dangerous, which spread to 163 countries and 6 continents and caused a major public health emergency worldwide. The outbreak is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) originated from bats, which spreads rapidly from human to human. As of 17 March 2020, there have been 179,112 confirmed cases and 7426 deaths worldwide, with a mortality rate of 4.1%. There is currently no effective treatment or approved vaccine, so isolating the source of infection and blocking the routes of transmission is important. In this article, we summarized the worldwide epidemic trend of COVID-19 and discussed its epidemiological characteristics, prevention and control measures. We hope this article could provide experience and help for global epidemic prevention and control.","Int J Environ Health Res","Yang, Chenglei","Qiu, Xue","Fan, Haoran","Jiang, Mei","Lao, Xiaojie","Zeng, Yukeng","Zhang, Zhiming","32316751"],"abstract":["There have been three major global outbreaks of acute respiratory disease caused by coronavirus in the last two decades. The ongoing Coronavirus Disease 2019 (COVID-19) first emerged in Wuhan, China, is the most dangerous, which spread to 163 countries and 6 continents and caused a major public health emergency worldwide. The outbreak is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) originated from bats, which spreads rapidly from human to human. As of 17 March 2020, there have been 179,112 confirmed cases and 7426 deaths worldwide, with a mortality rate of 4.1%. There is currently no effective treatment or approved vaccine, so isolating the source of infection and blocking the routes of transmission is important. In this article, we summarized the worldwide epidemic trend of COVID-19 and discussed its epidemiological characteristics, prevention and control measures. We hope this article could provide experience and help for global epidemic prevention and control."],"journal":"Int J Environ Health Res","authors":["Yang, Chenglei","Qiu, Xue","Fan, Haoran","Jiang, Mei","Lao, Xiaojie","Zeng, Yukeng","Zhang, Zhiming"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32316751","week":"202017|Apr 20 - Apr 26","doi":"10.1080/09603123.2020.1747602","keywords":["covid-19","epidemiology","sars-cov-2"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664815087629631488,"score":8.518259,"similar":[{"pmid":32315723,"title":"The epidemiological and clinical features of COVID-19 and lessons from this global infectious public health event.","text":["The epidemiological and clinical features of COVID-19 and lessons from this global infectious public health event.","Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and represents a potentially fatal disease of great global public health importance. As of March 26, 2020, the outbreak of COVID-19 has resulted in 462,801 confirmed cases and 20,839 deaths globally, which is more than those caused by SARS and Middle East respiratory syndrome (MERS) in 2003 and 2013, respectively. The epidemic has posed considerable challenges worldwide. Under a strict mechanism of massive prevention and control, China has seen a rapid decrease in new cases of coronavirus; however, the global situation remains serious. Additionally, the origin of COVID-19 has not been determined and no specific antiviral treatment or vaccine is currently available. Based on the published data, this review systematically discusses the etiology, epidemiology, clinical characteristics, and current intervention measures related to COVID-19 in the hope that it may provide a reference for future studies and aid in the prevention and control of the COVID-19 epidemic.","J Infect","Tu, Huilan","Tu, Sheng","Gao, Shiqi","Shao, Anwen","Sheng, Jifang","32315723"],"abstract":["Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and represents a potentially fatal disease of great global public health importance. As of March 26, 2020, the outbreak of COVID-19 has resulted in 462,801 confirmed cases and 20,839 deaths globally, which is more than those caused by SARS and Middle East respiratory syndrome (MERS) in 2003 and 2013, respectively. The epidemic has posed considerable challenges worldwide. Under a strict mechanism of massive prevention and control, China has seen a rapid decrease in new cases of coronavirus; however, the global situation remains serious. Additionally, the origin of COVID-19 has not been determined and no specific antiviral treatment or vaccine is currently available. Based on the published data, this review systematically discusses the etiology, epidemiology, clinical characteristics, and current intervention measures related to COVID-19 in the hope that it may provide a reference for future studies and aid in the prevention and control of the COVID-19 epidemic."],"journal":"J Infect","authors":["Tu, Huilan","Tu, Sheng","Gao, Shiqi","Shao, Anwen","Sheng, Jifang"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32315723","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jinf.2020.04.011","keywords":["2019-ncov","covid-19","epidemiology","intervention","sars-cov-2"],"source":"PubMed","topics":["Prevention","Diagnosis"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664714519994171392,"score":181.59895},{"pmid":32220177,"title":"[Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review].","text":["[Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review].","This review summarizes the ongoing researches regarding etiology, epidemiology, transmission dynamics, treatment, and prevention and control strategies of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with comparison to severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and pandemic H1N1 virus. SARS-CoV-2 may be originated from bats, and the patients and asymptomatic carriers are the source of epidemic infection. The virus can be transmitted human-to-human through droplets and close contact, and people at all ages are susceptible to this virus. The main clinical symptoms of the patients are fever and cough, accompanied with leukocytopenia and lymphocytopenia. Effective drugs have been not yet available thus far. In terms of the prevention and control strategies, vaccine development as the primary prevention should be accelerated. Regarding the secondary prevention, ongoing efforts of the infected patients and close contacts quarantine, mask wearing promotion, regular disinfection in public places should be continued. Meanwhile, rapid detection kit for serological monitoring of the virus in general population is expected so as to achieve early detection, early diagnosis, early isolation and early treatment. In addition, public health education on this disease and prevention should be enhanced so as to mitigate panic and mobilize the public to jointly combat the epidemic.","Sichuan Da Xue Xue Bao Yi Xue Ban","Luan, Rong-Sheng","Wang, Xin","Sun, Xin","Chen, Xing-Shu","Zhou, Tao","Liu, Quan-Hui","Lu, Xin","Wu, Xian-Ping","Gu, Dong-Qing","Tang, Ming-Shuang","Cui, Hui-Jie","Shan, Xue-Feng","Ouyang, Jing","Zhang, Ben","Zhang, Wei","Sichuan University Covid-, Emergency Research Group","32220177"],"abstract":["This review summarizes the ongoing researches regarding etiology, epidemiology, transmission dynamics, treatment, and prevention and control strategies of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with comparison to severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and pandemic H1N1 virus. SARS-CoV-2 may be originated from bats, and the patients and asymptomatic carriers are the source of epidemic infection. The virus can be transmitted human-to-human through droplets and close contact, and people at all ages are susceptible to this virus. The main clinical symptoms of the patients are fever and cough, accompanied with leukocytopenia and lymphocytopenia. Effective drugs have been not yet available thus far. In terms of the prevention and control strategies, vaccine development as the primary prevention should be accelerated. Regarding the secondary prevention, ongoing efforts of the infected patients and close contacts quarantine, mask wearing promotion, regular disinfection in public places should be continued. Meanwhile, rapid detection kit for serological monitoring of the virus in general population is expected so as to achieve early detection, early diagnosis, early isolation and early treatment. In addition, public health education on this disease and prevention should be enhanced so as to mitigate panic and mobilize the public to jointly combat the epidemic."],"journal":"Sichuan Da Xue Xue Bao Yi Xue Ban","authors":["Luan, Rong-Sheng","Wang, Xin","Sun, Xin","Chen, Xing-Shu","Zhou, Tao","Liu, Quan-Hui","Lu, Xin","Wu, Xian-Ping","Gu, Dong-Qing","Tang, Ming-Shuang","Cui, Hui-Jie","Shan, Xue-Feng","Ouyang, Jing","Zhang, Ben","Zhang, Wei","Sichuan University Covid-, Emergency Research Group"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32220177","week":"202013|Mar 23 - Mar 29","doi":"10.12182/20200360505","keywords":["coronavirus disease 2019","epidemic prevention and control","epidemiology","treatment"],"source":"PubMed","topics":["Mechanism","Diagnosis","Treatment","Prevention"],"weight":1,"_version_":1664638742957129728,"score":160.97206},{"pmid":32036774,"pmcid":"PMC7054940","title":"Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments.","text":["Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments.","Coronaviruses are the well-known cause of severe respiratory, enteric and systemic infections in a wide range of hosts including man, mammals, fish, and avian. The scientific interest on coronaviruses increased after the emergence of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) outbreaks in 2002-2003 followed by Middle East Respiratory Syndrome CoV (MERS-CoV). This decade's first CoV, named 2019-nCoV, emerged from Wuhan, China, and declared as 'Public Health Emergency of International Concern' on January 30(th), 2020 by the World Health Organization (WHO). As on February 4, 2020, 425 deaths reported in China only and one death outside China (Philippines). In a short span of time, the virus spread has been noted in 24 countries. The zoonotic transmission (animal-to-human) is suspected as the route of disease origin. The genetic analyses predict bats as the most probable source of 2019-nCoV though further investigations needed to confirm the origin of the novel virus. The ongoing nCoV outbreak highlights the hidden wild animal reservoir of the deadly viruses and possible threat of spillover zoonoses as well. The successful virus isolation attempts have made doors open for developing better diagnostics and effective vaccines helping in combating the spread of the virus to newer areas.","Vet Q","Malik, Yashpal Singh","Sircar, Shubhankar","Bhat, Sudipta","Sharun, Khan","Dhama, Kuldeep","Dadar, Maryam","Tiwari, Ruchi","Chaicumpa, Wanpen","32036774"],"abstract":["Coronaviruses are the well-known cause of severe respiratory, enteric and systemic infections in a wide range of hosts including man, mammals, fish, and avian. The scientific interest on coronaviruses increased after the emergence of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) outbreaks in 2002-2003 followed by Middle East Respiratory Syndrome CoV (MERS-CoV). This decade's first CoV, named 2019-nCoV, emerged from Wuhan, China, and declared as 'Public Health Emergency of International Concern' on January 30(th), 2020 by the World Health Organization (WHO). As on February 4, 2020, 425 deaths reported in China only and one death outside China (Philippines). In a short span of time, the virus spread has been noted in 24 countries. The zoonotic transmission (animal-to-human) is suspected as the route of disease origin. The genetic analyses predict bats as the most probable source of 2019-nCoV though further investigations needed to confirm the origin of the novel virus. The ongoing nCoV outbreak highlights the hidden wild animal reservoir of the deadly viruses and possible threat of spillover zoonoses as well. The successful virus isolation attempts have made doors open for developing better diagnostics and effective vaccines helping in combating the spread of the virus to newer areas."],"journal":"Vet Q","authors":["Malik, Yashpal Singh","Sircar, Shubhankar","Bhat, Sudipta","Sharun, Khan","Dhama, Kuldeep","Dadar, Maryam","Tiwari, Ruchi","Chaicumpa, Wanpen"],"date":"2020-02-11T11:00:00Z","year":2020,"_id":"32036774","week":"20207|Feb 10 - Feb 16","doi":"10.1080/01652176.2020.1727993","keywords":["2019-ncov","coronavirus","middle east respiratory syndrome cov","public health emergency","severe acute respiratory syndrome cov","genetic analyses","reservoir host","therapeutics","vaccines","zoonoses"],"source":"PubMed","topics":["Mechanism","Transmission","Treatment","Diagnosis"],"weight":1,"locations":["Wuhan","China","China","China","Philippines"],"countries":["China","Philippines"],"countries_codes":["CHN|China","PHL|Philippines"],"_version_":1664640875331846144,"score":154.51091},{"pmid":32078069,"pmcid":"PMC7033263","title":"2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies.","text":["2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies.","An ongoing outbreak of 2019-nCoV pneumonia was first identified in Wuhan, Hubei province, China at the end of 2019. With the spread of the new coronavirus accelerating, person-to-person transmission in family homes or hospitals, and intercity spread of 2019-nCoV occurred. At least 40,261 cases confirmed, 23,589 cases suspected, 909 cases death and 3444 cases cured in China and worldwide 24 countries confirmed 383 cases being diagnosed, 1 case death in February 10th, 2020. At present, the mortality of 2019-nCoV in China is 2.3%, compared with 9.6% of SARS and 34.4% of MERS reported by WHO. It seems the new virus is not as fatal as many people thought. Chinese authorities improved surveillance network, made the laboratory be able to recognize the outbreak within a few weeks and announced the virus genome that provide efficient epidemiological control. More comprehensive information is required to understand 2019-nCoV feature, the epidemiology of origin and spreading, and the clinical phenomina. According to the current status, blocking transmission, isolation, protection, and alternative medication are the urgent management strategies against 2019-nCoV.","Clin Transl Med","She, Jun","Jiang, Jinjun","Ye, Ling","Hu, Lijuan","Bai, Chunxue","Song, Yuanlin","32078069"],"abstract":["An ongoing outbreak of 2019-nCoV pneumonia was first identified in Wuhan, Hubei province, China at the end of 2019. With the spread of the new coronavirus accelerating, person-to-person transmission in family homes or hospitals, and intercity spread of 2019-nCoV occurred. At least 40,261 cases confirmed, 23,589 cases suspected, 909 cases death and 3444 cases cured in China and worldwide 24 countries confirmed 383 cases being diagnosed, 1 case death in February 10th, 2020. At present, the mortality of 2019-nCoV in China is 2.3%, compared with 9.6% of SARS and 34.4% of MERS reported by WHO. It seems the new virus is not as fatal as many people thought. Chinese authorities improved surveillance network, made the laboratory be able to recognize the outbreak within a few weeks and announced the virus genome that provide efficient epidemiological control. More comprehensive information is required to understand 2019-nCoV feature, the epidemiology of origin and spreading, and the clinical phenomina. According to the current status, blocking transmission, isolation, protection, and alternative medication are the urgent management strategies against 2019-nCoV."],"journal":"Clin Transl Med","authors":["She, Jun","Jiang, Jinjun","Ye, Ling","Hu, Lijuan","Bai, Chunxue","Song, Yuanlin"],"date":"2020-02-21T11:00:00Z","year":2020,"_id":"32078069","week":"20208|Feb 17 - Feb 23","doi":"10.1186/s40169-020-00271-z","keywords":["2019-ncov","hand hygiene","isolation","respiratory and eye protection","transmission"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Wuhan","Hubei","China","China","China","Chinese","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640875223842820,"score":150.84937},{"pmid":32161092,"title":"The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options.","text":["The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options.","The new decade of the 21(st) century (2020) started with the emergence of novel coronavirus known as SARS-CoV-2 that caused an epidemic of coronavirus disease (COVID-19) in Wuhan, China. It is the third highly pathogenic and transmissible coronavirus after severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in humans. The source of origin, transmission to humans and mechanisms associated with the pathogenicity of SARS-CoV-2 are not clear yet, however, its resemblance with SARS-CoV and several other bat coronaviruses was recently confirmed through genome sequencing related studies. The development of therapeutic strategies is necessary in order to prevent further epidemics and cure infected people. In this Review, we summarize current information about the emergence, origin, diversity, and epidemiology of three pathogenic coronaviruses with a specific focus on the current outbreak in Wuhan, China. Furthermore, we discuss the clinical features and potential therapeutic options that may be effective against SARS-CoV-2.","J Clin Microbiol","Khan, Suliman","Siddique, Rabeea","Shereen, Muhammad Adnan","Ali, Ashaq","Liu, Jianbo","Bai, Qian","Bashir, Nadia","Xue, Mengzhou","32161092"],"abstract":["The new decade of the 21(st) century (2020) started with the emergence of novel coronavirus known as SARS-CoV-2 that caused an epidemic of coronavirus disease (COVID-19) in Wuhan, China. It is the third highly pathogenic and transmissible coronavirus after severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in humans. The source of origin, transmission to humans and mechanisms associated with the pathogenicity of SARS-CoV-2 are not clear yet, however, its resemblance with SARS-CoV and several other bat coronaviruses was recently confirmed through genome sequencing related studies. The development of therapeutic strategies is necessary in order to prevent further epidemics and cure infected people. In this Review, we summarize current information about the emergence, origin, diversity, and epidemiology of three pathogenic coronaviruses with a specific focus on the current outbreak in Wuhan, China. Furthermore, we discuss the clinical features and potential therapeutic options that may be effective against SARS-CoV-2."],"journal":"J Clin Microbiol","authors":["Khan, Suliman","Siddique, Rabeea","Shereen, Muhammad Adnan","Ali, Ashaq","Liu, Jianbo","Bai, Qian","Bashir, Nadia","Xue, Mengzhou"],"date":"2020-03-13T11:00:00Z","year":2020,"_id":"32161092","week":"202011|Mar 09 - Mar 15","doi":"10.1128/JCM.00187-20","source":"PubMed","topics":["Treatment"],"weight":1,"locations":["Wuhan","China","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640874792878082,"score":147.72234}]}